Strong Aerospace Demand Drives Astronics to Record Q2 and Upbeat Outlook
Astronics reported record Q2 sales of $260M (+27%), strong profit margins, and raised 2026 revenue guidance to $1.02–$1.04B, beating estimates.
Astronics reported record Q2 sales of $260M (+27%), strong profit margins, and raised 2026 revenue guidance to $1.02–$1.04B, beating estimates.
CoreWeave raises full-year guidance and CapEx to $35-39B after Q2, with revenue backlog hitting $104.2B amid strong AI demand.
Record backlog and >$60B in new orders drove SMCI’s after-hours jump. FY2027 revenue guided to $65–72B, far above the $52.5B consensus.
Must file restated financials by Sept. 14 or face Nasdaq delisting.
Mereo BioPharma shares rose ~27% after a key option-and-license deal for alvelestat with Sentynl and an updated cash runway into late 2027.
After securing Commerce Department backing, Intel upsized its share sale to $20 billion. Proceeds will support the Ohio factory and AI growth.